hepatitis_c_virus_hcv_for_egyptian_patients

Egyptian patients who underwent treatment dosages for HCV about 18 months. Discretization should be applied based on expert recommendations; there is an attached file shows how. Age Age Gender Gender BMI Body Mass Index Fever Fever Nausea/Vomting Nausea/Vomting Headache Headache Diarrhea Diarrhea Fatigue & generalized bone ache Fatigue & generalized bone ache Jaundice Jaundice Epigastric pain Epigastric pain WBC White blood cell RBC red blood cells HGB Hemoglobin Plat Platelets AST 1 aspartate transaminase ratio ALT 1 alanine transaminase ratio 1 week ALT 4 alanine transaminase ratio 12 weeks ALT 12 alanine transaminase ratio 4 weeks ALT 24 alanine transaminase ratio 24 weeks ALT 36 alanine transaminase ratio 36 weeks ALT 48 alanine transaminase ratio 48 weeks ALT after 24 w alanine transaminase ratio 24 weeks RNA Base RNA Base RNA 4 RNA 4 RNA 12 RNA 12 RNA EOT RNA end-of-treatment RNA EF RNA Elongation Factor Baseline histological Grading Baseline histological Grading Baselinehistological staging Baselinehistological staging A novel model based on non invasive methods for prediction of liver fibrosis By Mahmoud Nasr, Khaled El-Bahnasy, M. Hamdy, S. Kamal. 2017 Published in International Computer Engineering Conference